Advertisement

Topics

Alliance Pharma grows strongly as overseas revenues pass domestic sales for the first time

03:47 EDT 26 Mar 2019 | Proactive Investors

“In 2018 we continued to deliver on our strategy, with strong sales and profit growth, led by our international star brands and acquisitions. 2018 marked a milestone in the internationalisation of Alliance in that, for the first time, our overseas sales exceeded those in the UK,” said CEO Peter Butterfield

Original Article: Alliance Pharma grows strongly as overseas revenues pass domestic sales for the first time

NEXT ARTICLE

More From BioPortfolio on "Alliance Pharma grows strongly as overseas revenues pass domestic sales for the first time"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...